Researchers have identified a dual therapeutic strategy that combined inhibition of a key SARS-CoV-2 viral enzyme with suppression of a host inflammatory pathway, with preclinical evidence that ...

C OVID-19 may leave a lasting impression on the brain, even in people who fully recover from their infection. New research ...

The discovery could serve as a starting point for antiviral strategies. A research team at Ruhr University Bochum, Germany, has identified a previously unknown cellular mechanism crucial to the ...

Long after the acute infection fades, pieces of the virus behind COVID-19 can linger in the body and quietly sabotage the ...

The COVID-19 medications Nirmatrelvir-Ritonavir and Molnupiravir show effectiveness against virus replication in at-risk patients. Data from over 290,000 PCR tests in Vienna indicate a rapid reduction ...

"We really don't know how that happened." Scientists stunned after virus jumps between humans and animals: 'It was a very unusual situation' first appeared on The Cool Down.

The US FDA has approved two companies’ COVID vaccines that target the latest variant of the virus for adults aged at least 65 years and individuals at high risk for severe outcomes, according to ...

Heart inflammation caused by the mRNA COVID vaccines is rare. The COVID vaccines have saved millions of lives from a virus that has killed more than seven million people globally. Many safety studies ...

A virus-agnostic nasal spray called ‘INNA-051’ was designed to increase innate immunity and prevent respiratory illnesses ...